FindTrial
Sign In

Knowledge, Attitudes, and Practices in Managing Type 2 Diabetes Mellitus with High Cardio-Renal Risk and HbA1c greater than 7%

A Cross-Sectional Survey Evaluating Physicians Knowledge, Attitudes, and Practices in the Management of Type 2 Diabetes Mellitus with High Cardio-Renal Risk and HbA1c greater than 7% - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112915
Enrollment
300
Registered
2026-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr. Reddys Laboratories Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthcare professionals practicing in India MBBS (with Diploma in Diabetology) or MD (Medicine) Minimum 5 years (post-MBBS) clinical experience in managing T2DM and associated cardio-renal risk

Exclusion criteria

Exclusion criteria: Not willing to participate or provide informed consent

Design outcomes

Primary

MeasureTime frame
Assessment of healthcare professionals awareness perceptions and real-world clinical practices regarding guideline directed treatment initiation and optimization in patients with T2DM and high cardio renal risk (HbA1c more than 7%) including therapeutic decision-making use of SGLT2 inhibitor based and combination therapies patient monitoring and adherence considerations and barriers or facilitators influencing timely treatment optimizationTimepoint: Day 1—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Simran Chhatwal

Dr. Reddys Laboratories Limited

simranchhatwal@drreddys.com9582711359

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026